Bienville Capital Management’s Gilead Sciences GILD Stock Holding History

Bienville Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-4,670	Closed	-$359K	–	144
2020 Q2	$359K	Buy	+4,670	New	+$358K	0.03%	92
2020 Q1	–	Sell	-7,500	Closed	-$487K	–	121
2019 Q4	$487K	Hold	7,500	–	–	0.12%	34
2019 Q3	$475K	Sell	7,500 -695	-8%	-$45.4K	0.06%	35
2019 Q2	$554K	Buy	8,195 +601	+8%	+$39.5K	0.07%	80
2019 Q1	$494K	Buy	7,594 +18	+0.2%	+$1.2K	0.06%	81
2018 Q4	$474K	Sell	7,576 -305	-4%	-$21.3K	0.09%	77
2018 Q3	$608K	Buy	7,881 +16	+0.2%	+$1.21K	0.05%	45
2018 Q2	$557K	Sell	7,865 -61	-0.8%	-$4.31K	0.05%	59
2018 Q1	$598K	Buy	7,926 +24	+0.3%	+$1.91K	0.09%	58
2017 Q4	$566K	Buy	7,902 +71	+0.9%	+$5.39K	0.1%	83
2017 Q3	$634K	Sell	7,831 -2,094	-21%	-$160K	0.11%	59
2017 Q2	$702K	Buy	9,925 +1,535	+18%	+$102K	0.2%	51
2017 Q1	$570K	Buy	+8,390	New	+$590K	0.13%	59
2015 Q1	–	Sell	-6,000	Closed	-$566K	–	69
2014 Q4	$566K	Buy	+6,000	New	+$621K	0.47%	35

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bienville Capital Management's GILD Position: Q3 2020 in Review

Bienville Capital Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 4,670 shares — an estimated $359K sold.

Bienville Capital Management first reported a position in GILD in Q4 2014 and held it in 14 quarters. The position peaked at $702K in Q2 2017. 1,539 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Bienville Capital Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Bienville Capital Management sold 4,670 Gilead Sciences shares in Q3 2020, an estimated $359K.
Bienville Capital Management first reported a position in Gilead Sciences in Q4 2014 and held it in 14 quarters.
Bienville Capital Management's Gilead Sciences position peaked at $702K in Q2 2017.
1,539 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Bienville Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.